Select Publications
Journal articles
2015, 'Optimal radiotherapy utilisation rate in developing countries: An IAEA study', Radiotherapy and Oncology, 116, pp. 35 - 37, http://dx.doi.org/10.1016/j.radonc.2015.06.012
,2015, 'The impact of cancer incidence and stage on optimal utilization of radiotherapy: Methodology of a population based analysis by the ESTRO-HERO project', Radiotherapy and Oncology, 116, pp. 45 - 50, http://dx.doi.org/10.1016/j.radonc.2015.04.021
,2015, 'The optimal utilization proportion of external beam radiotherapy in European countries: An ESTRO-HERO analysis', Radiotherapy and Oncology, 116, pp. 38 - 44, http://dx.doi.org/10.1016/j.radonc.2015.04.018
,2015, 'The Cancer, Lifestyle and Evaluation of Risk Study (CLEAR): Rationale and design of an unmatched "case-spouse control" study of over 10,000 participants in New South Wales, Australia', Cancer Epidemiology, 39, pp. 414 - 423, http://dx.doi.org/10.1016/j.canep.2015.03.006
,2015, 'Factors affecting the use of single-fraction radiotherapy for the palliation of bone metastases in Australia', Clinical Oncology, 27, pp. 205 - 212, http://dx.doi.org/10.1016/j.clon.2014.11.027
,2015, 'The population benefit of radiotherapy for cervical cancer: Local control and survival estimates for optimally utilized radiotherapy and chemoradiation', Radiotherapy and Oncology, 114, pp. 389 - 394, http://dx.doi.org/10.1016/j.radonc.2015.02.005
,2015, 'Evidence-based Estimates of the Demand for Radiotherapy', Clinical Oncology, 27, pp. 70 - 76, http://dx.doi.org/10.1016/j.clon.2014.10.005
,2015, 'Radiation Therapy and the Global Health Agenda', Clinical Oncology, 27, pp. 67 - 69, http://dx.doi.org/10.1016/j.clon.2014.11.025
,2015, 'Estimation of an optimal chemotherapy utilisation rate for upper gastrointestinal cancers: Setting an evidence-based benchmark for the best-quality cancer care', Gastroenterology Research and Practice, 2015, http://dx.doi.org/10.1155/2015/753480
,2015, 'Estimation of the optimal number of radiotherapy fractions for breast cancer: A review of the evidence', Radiotherapy and Oncology, 116, pp. 174 - 178, http://dx.doi.org/10.1016/j.radonc.2015.07.015
,2015, 'Patterns of care study of brachytherapy in New South Wales: Malignancies of the uterine corpus', Journal of Contemporary Brachytherapy, 7, pp. 224 - 230, http://dx.doi.org/10.5114/jcb.2015.52623
,2015, '120PD An estimation of the population-based survival benefit of first-line chemotherapy for adult primary malignant brain tumour', Annals of Oncology, 26, pp. ix34 - ix34, http://dx.doi.org/10.1093/annonc/mdv520.04
,2015, 'An Estimation of the Population-Based Survival Benefit of First-Line Chemotherapy for Lung Cancer', Annals of Oncology, 26, pp. i29 - i29, http://dx.doi.org/10.1093/annonc/mdv050.37
,2015, 'OC-0192: Optimal radiotherapy utilization rate in developing countries: an IAEA study', Radiotherapy and Oncology, 115, pp. S96 - S97, http://dx.doi.org/10.1016/s0167-8140(15)40190-2
,2015, 'OC-0193: Current radiotherapy capacity in post-Soviet countries; an IAEA survey', Radiotherapy and Oncology, 115, pp. S97 - S98, http://dx.doi.org/10.1016/s0167-8140(15)40191-4
,2014, 'Prostate brachytherapy in New South Wales: Patterns of care study and impact of caseload on treatment quality', Journal of Contemporary Brachytherapy, 6, pp. 344 - 349, http://dx.doi.org/10.5114/jcb.2014.46610
,2014, '606PAN ESTIMATION OF THE POPULATION SURVIVAL BENEFIT OF FIRST-LINE CHEMOTHERAPY FOR GASTROINTESTINAL CANCER.', Ann Oncol, 25, pp. iv206 - iv207, http://dx.doi.org/10.1093/annonc/mdu333.107
,2014, 'Estimating the demand for radiotherapy from the evidence: A review of changes from 2003 to 2012', Radiotherapy and Oncology, 112, pp. 140 - 144, http://dx.doi.org/10.1016/j.radonc.2014.03.024
,2014, 'Patterns of care study of brachytherapy in New South Wales: Cervical cancer treatment quality depends on caseload', Journal of Contemporary Brachytherapy, 6, pp. 28 - 32, http://dx.doi.org/10.5114/jcb.2014.42022
,2014, 'Patterns of Retreatment by Radiotherapy', Clinical Oncology, 26, pp. 611 - 618, http://dx.doi.org/10.1016/j.clon.2014.03.008
,2014, 'The Australian Magnetic Resonance Imaging-Linac Program', Seminars in Radiation Oncology, 24, pp. 203 - 206, http://dx.doi.org/10.1016/j.semradonc.2014.02.015
,2013, 'Poor outcomes after whole brain radiotherapy in patients with brain metastases: Results from an international multicentre cohort study', Clinical Oncology, 25, pp. 674 - 680, http://dx.doi.org/10.1016/j.clon.2013.07.002
,2013, 'Radiotherapy - A leap forward in cancer care', Cancer Forum, 37, pp. 42 - 46
,2013, 'Estimation of the optimal brachytherapy utilization rate in the treatment of gynecological cancers and comparison with patterns of care', International Journal of Radiation Oncology and Biology Physics, 85, pp. 400 - 405, http://dx.doi.org/10.1016/j.ijrobp.2012.04.014
,2013, 'OC-0367: New evidence-based benchmarks for radiotherapy service provision', Radiotherapy and Oncology, 106, pp. S143 - S144, http://dx.doi.org/10.1016/s0167-8140(15)32673-6
,2013, 'Referral pathways in colorectal cancer: An audit of surgeons records', Australian Health Review, http://dx.doi.org/10.1071/AH13038
,2013, 'The potential for an enhanced role for MRI in radiation-therapy treatment planning', Technology in Cancer Research and Treatment, 12, pp. 429 - 446, http://dx.doi.org/10.7785/tcrt.2012.500342
,2013, 'The varying role of the GP in the pathway between colonoscopy and surgery for colorectal cancer: a retrospective cohort study', BMJ Open, 3, pp. 1 - 13, http://dx.doi.org/10.1136/bmjopen-2012-002325
,2012, 'A comparison of surgical and radiotherapy breast cancer therapy utilization in Canada (British Columbia), Scotland (Dundee), and Australia (Western Australia) with models of "optimal" therapy', Breast, 21, pp. 570 - 577, http://dx.doi.org/10.1016/j.breast.2012.02.014
,2012, 'A comparison of systemic breast cancer therapy utilization in Canada (British Columbia), Scotland (Dundee), and Australia (Western Australia) with models of “optimal” therapy', Breast, 21, pp. 562 - 569, http://dx.doi10.1016/j.breast.2012.01.006
,2012, 'Estimation of the optimal brachytherapy utilisation rate in the treatment of vaginal cancer and comparison with patterns of care', Journal of medical imaging & radiation oncology, 56, pp. 483 - 489, http://dx.doi.org/10.1111/j.1754-9485.2012.02392.x
,2012, 'Socio-demographic and other patient characteristics associated with time between colonoscopy and surgery, and choice of treatment centre for colorectal cancer: a retrospective cohort study', BMJ Open, 2, pp. e001070, http://dx.doi.org/10.1136/bmjopen-2012-001070
,2012, 'The shortage of medical oncologists: The Australian medical oncologist workforce study', Medical Journal of Australia, 196, pp. 58 - 61, http://dx.doi.org/10.5694/mja11.10363
,2012, 'Workforce shortages in medical oncology: A looming threat to quality cancer care', Medical Journal of Australia, 196, pp. 32 - 33, http://dx.doi.org/10.5694/mja11.10356
,2011, 'Estimation of an Optimal Chemotherapy Utilisation Rate for Primary Malignant Brain Tumours: an Evidence-based Benchmark for Cancer Care', CLINICAL ONCOLOGY, 23, pp. 48 - 54, http://dx.doi.org/10.1016/j.clon.2010.08.011
,2011, 'A decade of investment in radiotherapy in New South Wales: Why does the gap between optimal and actual persist?', Journal of Medical Imaging and Radiation Oncology, 55, pp. 411 - 433, http://dx.doi.org/10.1111/j.1754-9485.2011.02292.x
,2011, 'Chemotherapy in rectal cancer: variation in utilization and development of an evidencebased benchmark rate of optimal chemotherapy utilization', Clinical Colorectal Cancer, 10, pp. 102 - 107, http://dx.doi.org/10.1016/j.clcc.2011.03.005
,2011, 'Estimation of an optimal chemotherapy utilisation rate for primary malignant brain tumours: an evidence-based benchmark for cancer care', Clinical Oncology, 23, pp. 48 - 54, http://dx.doi.org/10.1016/j.clon.2010.08.011
,2011, 'Limited chemotherapy and shrinking field radiotherapy for osteolymphoma (primary bone lymphoma): Results from the Trans-Tasman radiation oncology group 99.04 and Australasian Leukaemia and lymphoma group LY02 prospective trial', International Journal of Radiation Oncology and Biology Physics, 80, pp. 1164 - 1170, http://dx.doi.org/10.1016/j.ijrobp.2010.03.036
,2010, 'A Comparison of Breast Cancer Treatment Rates in British Columbia, Scotland, and Western Australia, and a Comparison with Models of "Optimal" Therapy', CANCER RESEARCH, 70, http://dx.doi.org/10.1158/0008-5472.SABCS10-123-11-11
,2010, '‘GAP’ in radiotherapy services in Australia and New Zealand in 2009', Journal of Medical Imaging and Radiation Oncology, 54, pp. 287 - 297, http://dx.doi.org/10.1111/j.1754-9485.2010.02172.x
,2010, 'Chemotherapy in Head and Neck Cancers: Summary of Recommendations and a Critical Review of Clinical Practice Guidelines', The European Journal of Clinical and Medical Oncology, 2, pp. 65 - 71
,2010, 'Distance learning in the applied sciences of oncology', Radiotherapy and Oncology, 95, pp. 129 - 132, http://dx.doi.org/10.1016/j.radonc.2010.02.011
,2010, 'Estimation of an evidence-based benchmark for the optimal endocrine therapy utilization rate in breast cancer.', Breast, 19, pp. 345 - 349, http://dx.doi.org/10.1016/j.breast.2010.02.006
,2010, 'Estimation of an optimal chemotherapy utilisation rate for breast cancer: Setting an evidence-based benchmark for the best quality cancer care.', European Journal of Cancer, 46, pp. 703 - 712
,2010, 'Estimation of an optimal chemotherapy utilisation rate for lung cancer: An evidence-based benchmark for cancer care.', Lung Cancer, 69, pp. 307 - 314
,2010, 'Estimation of an optimal utilisation rate for palliative radiotherapy in newly diagnosed cancer patients', Clinical Oncology, 22, pp. 56 - 64
,2010, 'Management of Skin Toxicity during Radiation Therapy; A Review of the evidence.', Journal of medical imaging & radiation oncology, 54, pp. 264 - 279, http://dx.doi.org/10.1111/j.1754-9485.2010.02170.x
,2010, 'Patterns of Retreatment by Radiotherapy', Clinical Oncology, 23, pp. 10 - 18, http://dx.doi.org/10.1016/j.clon.2010.09.013
,2010, 'The ‘GAP’ in Radiotherapy Services in Australia and New Zealand in 2009.', Journal of medical imaging & radiation oncology, 54, pp. 287 - 297
,